Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) Other Non-Current Assets (2020 - 2024)

RAPT Therapeutics' Other Non-Current Assets history spans 5 years, with the latest figure at $389000.0 for Q3 2024.

  • For Q3 2024, Other Non-Current Assets fell 90.75% year-over-year to $389000.0; the TTM value through Sep 2024 reached $389000.0, down 90.75%, while the annual FY2023 figure was $3.9 million, 4.09% down from the prior year.
  • Other Non-Current Assets for Q3 2024 was $389000.0 at RAPT Therapeutics, down from $447000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $4.3 million in Q2 2023 and bottomed at $389000.0 in Q1 2020.
  • The 5-year median for Other Non-Current Assets is $447000.0 (2024), against an average of $1.9 million.
  • The largest annual shift saw Other Non-Current Assets skyrocketed 694.6% in 2022 before it plummeted 90.75% in 2024.
  • A 5-year view of Other Non-Current Assets shows it stood at $389000.0 in 2020, then soared by 651.16% to $2.9 million in 2021, then soared by 38.12% to $4.0 million in 2022, then dropped by 4.09% to $3.9 million in 2023, then tumbled by 89.95% to $389000.0 in 2024.
  • Per Business Quant, the three most recent readings for RAPT's Other Non-Current Assets are $389000.0 (Q3 2024), $447000.0 (Q2 2024), and $447000.0 (Q1 2024).